1. Home
  2. PMCB vs LUCY Comparison

PMCB vs LUCY Comparison

Compare PMCB & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • LUCY
  • Stock Information
  • Founded
  • PMCB 1996
  • LUCY 2017
  • Country
  • PMCB United States
  • LUCY United States
  • Employees
  • PMCB N/A
  • LUCY N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • LUCY Ophthalmic Goods
  • Sector
  • PMCB Health Care
  • LUCY Health Care
  • Exchange
  • PMCB Nasdaq
  • LUCY Nasdaq
  • Market Cap
  • PMCB 11.4M
  • LUCY 10.3M
  • IPO Year
  • PMCB N/A
  • LUCY 2022
  • Fundamental
  • Price
  • PMCB $1.24
  • LUCY $2.30
  • Analyst Decision
  • PMCB
  • LUCY Strong Buy
  • Analyst Count
  • PMCB 0
  • LUCY 1
  • Target Price
  • PMCB N/A
  • LUCY $20.00
  • AVG Volume (30 Days)
  • PMCB 15.0K
  • LUCY 15.2K
  • Earning Date
  • PMCB 03-17-2025
  • LUCY 05-13-2025
  • Dividend Yield
  • PMCB N/A
  • LUCY N/A
  • EPS Growth
  • PMCB N/A
  • LUCY N/A
  • EPS
  • PMCB 1.29
  • LUCY N/A
  • Revenue
  • PMCB N/A
  • LUCY $1,636,440.00
  • Revenue This Year
  • PMCB N/A
  • LUCY $542.00
  • Revenue Next Year
  • PMCB N/A
  • LUCY N/A
  • P/E Ratio
  • PMCB $1.00
  • LUCY N/A
  • Revenue Growth
  • PMCB N/A
  • LUCY 41.99
  • 52 Week Low
  • PMCB $1.22
  • LUCY $2.27
  • 52 Week High
  • PMCB $2.55
  • LUCY $27.20
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 30.59
  • LUCY 18.95
  • Support Level
  • PMCB $1.22
  • LUCY $2.45
  • Resistance Level
  • PMCB $1.40
  • LUCY $3.48
  • Average True Range (ATR)
  • PMCB 0.13
  • LUCY 0.27
  • MACD
  • PMCB -0.04
  • LUCY -0.05
  • Stochastic Oscillator
  • PMCB 3.90
  • LUCY 1.89

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.

Share on Social Networks: